Use access key #2 to skip to page content.
$73.00 -5.75 (-7.30%)
10/10/2008 4:02 PM

Genentech, Inc. (DNA)

CAPS Rating:
****

The Company is a biotechnology company that discovers, develops, manufactures, and commercializes biotherapeutics for unmet medical needs.

View All Commentary (DNA)

Recs

4

Avatar rodik (< 20) Submitted: 6/22/07 3:56 PM : Outperform Start Price: $74.87 DNA Score: 38.57

The best run biotechnology company and the best growing in the whole sector. A fair valuation is $120, while the stock is selling at around $76, coming down slowly from its high $100. We buy to possibly double our money in a year time.

Report this Post Replies: 1 | Reply

Avatar DNAstock (50.05) Submitted: 6/24/07 12:43 PM

Recs: 0 | Rec This

With positive adjuvant ( a much bigger market than metastatic) data on the way for Avastin and with more positive data from the new Herceptin cytotoxic combo agent for breast cancer, this is very much within the realm of posibility (if not probability).

Hang on to this one!

Report this Post Reply

Featured Broker Partners